BioSpace News Archive

The Board of Directors for Insight Medbotics, a start-up founded by MDA and the Centre for Surgical Invention and Innovation (CSii), are pleased to announce the appointment of Paul Chipperton as the company’s Chief Executive Officer & President.

Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a specialty pharmaceutical company dedicated to the development and commercialization of critical care products with a focus on anti-infective products in adjunct cancer care, unique prescription products and stem cell therapy, today announced updates delivered during its third Mino-Lok® Phase 3 trial-related webinar.

Specific Diagnostics announced today that the Department of Defense has awarded the Company a grant to utilize the Reveal Rapid AST System for rapid assessment of the efficacy of bacteriophage in expressing pathogens.

i2020, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced multiple start-up and follow-on investment rounds together with OrbiMed and a start-up investment in a European science-based venture, together with OrbiMed and BioGeneration Ventures (BGV).

BB106 is formulated for subcutaneous delivery, which could make ketamine-based pain management a viable alternative to opioids.

Zynerba Pharmaceuticals, Inc., the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters at the Society of Biological Psychiatry 2021 Virtual Meeting.

AVITA Medical, Inc., a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced it plans to release its fiscal third quarter 2021 financial results after the market closes on Thursday, May 13, 2021.

Highlights innovations for precision musculoskeletal oncology and complex orthopaedic procedures; sees growing industry adoption

Sonic Urges Company to Add Its Three Independent Nominees to Board to Bring the Exact Experience and Perspectives Adverum Desperately Needs

10x Genomics, Inc., announced the company will be participating in the upcoming BofA Securities 2021 Virtual Healthcare Conference.